May 29th, 2014
Large Study Uncovers New Details About the Role of Hypertension in CVD
Larry Husten, PHD
Although high blood pressure has long been recognized and studied as a cardiovascular risk factor, a large new study published in the Lancet provides a more detailed, granular view of the specific role of different forms of hypertension. Eleni Rapsomaniki and colleagues in the U.K. analyzed data from 1.25 million people without existing cardiovascular disease age 30 and […]
October 21st, 2013
Selections from Richard Lehman’s Literature Review: October 21st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include cholecalciferol to reduce BP in older patients with isolated systolic hypertension, the FREEDOM trial, and more.
December 20th, 2011
22 Years Later, Study Shows Life-Prolonging Effect of Antihypertensive Therapy
Larry Husten, PHD
After more than 20 years, the benefits of antihypertensive therapy are still evident, according to a new paper published in JAMA. John Kostis and colleagues performed a 22-year follow-up study on patients enrolled between 1985 and 1988 in the Systolic Hypertension in the Elderly Program (SHEP) trial. In 1991, SHEP found that low-dose chlorthalidone in 4736 elderly patients with isolated […]
NEJM Journal Watch — Recent Cardiology Articles- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?
- A Randomized Trial of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation
- An Early Look at a Novel Intranasal Loop Diuretic